For instance, Garros-Regulez et al. [145] have demonstrated that pharmacological inhibition of mTOR in glioma stem cells (GSCs) causes a reduction in the expression of SOX2 and SOX9, which are required for neural stem cell maintenance, thus decreasing GSCs self-renewal potential and proliferation. The gene discussed is MTOR; the disease is glioma.